Crohn’s disease, a long-term inflammatory bowel disease that currently cannot be cured, causes repeated flare-ups of symptoms ...

Gastro Center of Maryland (GCM), one of the state’s largest GI practices, announces expansion to serve more patients across the DMV. With locations in Annapolis, Bethesda, Columbia, Gaithersburg, ...

Primary sclerosing cholangitis (PSC) is a chronic, progressive inflammatory disease characterized by fibrosis and bile duct ...

Drug approvals this year have reflected the trend in clinical development of biologics shifting from intravenous to ...

Crohn's and Colitis Awareness Week runs from Monday, December 1, to Sunday, December 7. Here, one person living with Crohn's Disease shares five things he wishes he had known sooner ...

AbbVie secures Canadian support for Skyrizi in ulcerative colitis with new reimbursement recommendations and a completed pCPA agreement.

SKYRIZI® (risankizumab), an IL-23 inhibitor, received two consecutive positive reimbursement recommendations by Canada’s Drug ...

PN-943 (IBD Program) -- Oral, gut-restricted alpha-4-beta-7 integrin antagonist demonstrated greater than threefold improved ...

It's going to take a heroic effort for Auburn to upset Alabama, and Alex McPherson is finally giving himself the green light.

The first week of December marks Crohn's & Colitis Awareness Week. Since 1990, cases of inflammatory bowel disease (IBD) have ...

Here are some tips to manage irritable bowel disease (IBD) and protect your stomach during the holidays and beyond.

While guideline-concordant post-polypectomy colonoscopy surveillance was associated with a reduced risk of incident ...